Suppr超能文献

体内硝酸甘油的主动脉CYP3A生物活化研究。

Investigation of aortic CYP3A bioactivation of nitroglycerin in vivo.

作者信息

Yuan R, Sumi M, Benet L Z

机构信息

Department of Biopharmaceutical Sciences, University of California, San Francisco 94143-0446, USA.

出版信息

J Pharmacol Exp Ther. 1997 Jun;281(3):1499-505.

PMID:9190888
Abstract

Nitroglycerin (GTN) has been used to treat heart disease for many years. It is generally believed that GTN is a prodrug; however, the mechanism for GTN bioactivation remains unknown. Recent studies, using hepatic microsomes, have suggested the involvement of cytochrome P450 3A (CYP3A) in GTN biotransformation. Here, we used an animal model to test the hypothesis that aortic CYP3A plays a role in the bioactivation of GTN in vivo. Ketoconazole (KCZ), a potent CYP3A inhibitor, was given to rats (50 mg/kg i.p.) 1 hr before a bolus dose of GTN (2 mg/rat i.v.). KCZ decreased GTN-induced cGMP (cyclic guanosine monophosphate) levels by 20 to 30% (P < .05), without affecting basal or S-nitroso, N-acetyl penicillamine-induced levels of cGMP. When rats received dexamethasone (DEX, 30 mg/kg, 4 days i.p.), a strong CYP3A inducer, they exhibited a significant (approximately 50%) higher cGMP response to GTN than the control group. When rats received the combination treatment of both DEX and KCZ, they responded to GTN to the same extent as control rats. Although the effect of KCZ on aortic CYP3A activity cannot be detected (activity in control rats is below the detection limit), KCZ markedly inhibited CYP3A activity in rat livers (2.02 +/- 0.04 vs. 0.31 +/- 0.04 nmol/mg prot/min, P < .05, in control vs. KCZ-treated rats, respectively) and in DEX pretreated rat aorta (0.145 +/- 0.036 vs. 0.042 +/- 0.037 nmol/mg prot/min, P < .05, in rats treated with DEX alone vs. rats treated with both DEX and KCZ, respectively). KCZ did not elicit an effect on aortic glutathione S-transferases, another major metabolic enzyme responsible for GTN biotransformation. DEX enhanced the aortic GST mu activity by 3-fold. However, the activity of GST in aorta did not correlate with the cGMP response to GTN. In conclusion, our results demonstrate that CYP3A activity in aorta is correlated with GTN bioactivation in vivo, but the contribution of this enzyme to overall GTN bioactivation is limited.

摘要

硝酸甘油(GTN)用于治疗心脏病已有多年。人们普遍认为GTN是一种前体药物;然而,GTN生物活化的机制仍不清楚。最近利用肝微粒体进行的研究表明,细胞色素P450 3A(CYP3A)参与了GTN的生物转化。在此,我们使用动物模型来验证主动脉CYP3A在体内GTN生物活化中起作用这一假说。在给大鼠静脉推注一剂GTN(2mg/只)前1小时,腹腔注射强效CYP3A抑制剂酮康唑(KCZ,50mg/kg)。KCZ使GTN诱导的环磷酸鸟苷(cGMP)水平降低了20%至30%(P<.05),但不影响基础cGMP水平或S-亚硝基-N-乙酰青霉胺诱导的cGMP水平。当大鼠接受地塞米松(DEX,30mg/kg,腹腔注射4天),一种强效的CYP3A诱导剂时,它们对GTN的cGMP反应比对照组显著高(约50%)。当大鼠接受DEX和KCZ联合治疗时,它们对GTN的反应程度与对照大鼠相同。虽然无法检测到KCZ对主动脉CYP3A活性的影响(对照大鼠的活性低于检测限),但KCZ显著抑制大鼠肝脏中的CYP3A活性(对照大鼠与KCZ处理大鼠分别为2.02±0.04对0.31±0.04nmol/mg蛋白/min,P<.05)以及DEX预处理大鼠主动脉中的CYP3A活性(单独接受DEX处理的大鼠与接受DEX和KCZ联合处理的大鼠分别为0.145±0.036对0.042±0.037nmol/mg蛋白/min,P<.05)。KCZ对主动脉谷胱甘肽S-转移酶没有影响,后者是负责GTN生物转化的另一种主要代谢酶。DEX使主动脉GSTμ活性提高了3倍。然而,主动脉中GST的活性与对GTN的cGMP反应无关。总之,我们的结果表明主动脉中的CYP3A活性与体内GTN生物活化相关,但该酶对整体GTN生物活化的贡献有限。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验